Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Sabine Huenecke"'
Autor:
Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Christoph Schmid, Nadine Müller, Gesine Bug, Michaela Döring, Arend von Stackelberg, Johanna Tischer, Francis Ayuk, Gerald Wulf, Udo Holtick, Lisa‑Marie Pfeffermann, Bernd Jahrsdörfer, Hubert Schrezenmeier, Selim Kuci, Zyrafete Kuci, Anke Zens, Michael Tribanek, Robert Zeiser, Sabine Huenecke, Peter Bader
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/b531e2a3fa18414fbe6b2e7f1a58550c
Autor:
Halvard Bonig, Mareike Verbeek, Peter Herhaus, Krischan Braitsch, Gernot Beutel, Christoph Schmid, Nadine Müller, Gesine Bug, Michaela Döring, Arend von Stackelberg, Johanna Tischer, Francis Ayuk, Gerald Wulf, Udo Holtick, Lisa-Marie Pfeffermann, Bernd Jahrsdörfer, Hubert Schrezenmeier, Selim Kuci, Zyrafete Kuci, Anke Zens, Michael Tribanek, Robert Zeiser, Sabine Huenecke, Peter Bader
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Patients with steroid-refractory acute graft-versus-host disease (aGvHD) not tolerating/responding to ruxolitinib (RR-aGvHD) have a dismal prognosis. Methods We retrospectively assessed real-world outcomes of RR-aGvHD treated with
Externí odkaz:
https://doaj.org/article/1942e01c115d422bbf46c4611ede54dd
Autor:
Julius C. Enssle, Julia Campe, Alina Moter, Isabel Voit, Alec Gessner, Ika Weija Yu, Sebastian Wolf, Björn Steffen, Thomas Oellerich, Hubert Serve, Melanie Bremm, Sabine Huenecke, Michael Lohoff, Maria Vehreschild, Holger F Rabenau, Marek Widera, Sandra Ciesek, Michael A Rieger, Katharina Imkeller, Ivana von Metzler, Evelyn Ullrich
Publikováno v:
HemaSphere, Vol 7, p e11813df (2023)
Externí odkaz:
https://doaj.org/article/6eeb2754933a41cda4d00f46d489e306
Autor:
Natascha Piede, Melanie Bremm, Anne Farken, Lisa-Marie Pfeffermann, Claudia Cappel, Halvard Bonig, Theres Fingerhut, Laura Puth, Kathrin Vogelsang, Andreas Peinelt, Rolf Marschalek, Matthias Müller, Peter Bader, Zyrafete Kuçi, Selim Kuçi, Sabine Huenecke
Publikováno v:
Cells, Vol 12, Iss 6, p 850 (2023)
Mesenchymal stromal cells (MSCs) have the potential to suppress pathological activation of immune cells and have therefore been considered for the treatment of Graft-versus-Host-Disease. The clinical application of MSCs requires a process validation
Externí odkaz:
https://doaj.org/article/a7c755e7cf274e35b8578d2834c3ce95
Autor:
Andreas Peinelt, Melanie Bremm, Hermann Kreyenberg, Claudia Cappel, Julia Banisharif-Dehkordi, Stephanie Erben, Eva Rettinger, Andrea Jarisch, Roland Meisel, Paul-Gerhardt Schlegel, Olaf Beck, Gesine Bug, Jan-Henning Klusmann, Thomas Klingebiel, Sabine Huenecke, Peter Bader
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chimeric antigen receptor (CAR) T cell therapy is a potent new treatment option for relapsed or refractory hematologic malignancies. As the monitoring of CAR T cell kinetics can provide insights into the activity of the therapy, appropriate CAR T cel
Externí odkaz:
https://doaj.org/article/79daa92e8f4244719dcde74aa8452d48
Autor:
Annekathrin Heinze, Beatrice Grebe, Melanie Bremm, Sabine Huenecke, Tasleem Ah. Munir, Lea Graafen, Jochen T. Frueh, Michael Merker, Eva Rettinger, Jan Soerensen, Thomas Klingebiel, Peter Bader, Evelyn Ullrich, Claudia Cappel
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Neuroblastoma (NB) is the most common solid extracranial tumor in childhood. Despite therapeutic progress, prognosis in high-risk NB is poor and innovative therapies are urgently needed. Therefore, we addressed the potential cytotoxic capacity of int
Externí odkaz:
https://doaj.org/article/439d2ee84c6d456f9f5a2cce5888bc1f
Autor:
Ruth Duecker, Patrick C. Baer, Aileen Buecker, Sabine Huenecke, Lisa-Marie Pfeffermann, Ute Modlich, Shahrzad Bakhtiar, Peter Bader, Stefan Zielen, Ralf Schubert
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: Ataxia-telangiectasia (A-T) is a multisystem disorder with progressive cerebellar ataxia, immunodeficiency, chromosomal instability, and increased cancer susceptibility. Cellular immunodeficiency is based on naïve CD4+ and CD8+ T-cell ly
Externí odkaz:
https://doaj.org/article/e8754e915039445e99bd174d0002e63f
Autor:
Melanie Bremm, Lisa-Marie Pfeffermann, Claudia Cappel, Verena Katzki, Stephanie Erben, Sibille Betz, Andrea Quaiser, Michael Merker, Halvard Bonig, Michael Schmidt, Thomas Klingebiel, Peter Bader, Sabine Huenecke, Eva Rettinger
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Cytokine-induced killer (CIK) cells are an immunotherapeutic approach to combat relapse following allogeneic hematopoietic stem cell transplantation (HSCT) in acute leukemia or myelodysplastic syndrome (MDS) patients. Prompt and sequential administra
Externí odkaz:
https://doaj.org/article/2b410e20b4ca4cdc83f38cb8aef2ef96
Autor:
Shahrzad Bakhtiar, Sandra Woelke, Sabine Huenecke, Matthias Kieslich, Alexander Malcolm Taylor, Ralf Schubert, Stefan Zielen, Peter Bader
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Ataxia telangiectasia (A-T) is a primary immunodeficiency with mutations in the gene encoding the A-T mutated (ATM) protein that interacts with immune, hematopoietic, and endocrine targets resulting in broad multi-systemic clinical manifestations wit
Externí odkaz:
https://doaj.org/article/2662370b206b47bbb61eee6f65ab2650
Autor:
Emilia Salzmann-Manrique, Melanie Bremm, Sabine Huenecke, Milena Stech, Andreas Orth, Matthias Eyrich, Ansgar Schulz, Ruth Esser, Thomas Klingebiel, Peter Bader, Eva Herrmann, Ulrike Koehl
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Rapid immune reconstitution (IR) following stem cell transplantation (SCT) is essential for a favorable outcome. The optimization of graft composition should not only enable a sufficient IR but also improve graft vs. leukemia/tumor effects, overcome
Externí odkaz:
https://doaj.org/article/5e424022dafd4153adc10b37c79f4510